Jorge Monge, MD

Professional Titles

• Assistant Professor of Medicine

Publications

• Monge J, Razavi M, Bao L, Patel SS. Two p53s in a Pod: Co-occurring plasma cell myeloma and therapy-related myeloid neoplasm following lenalidomide therapy. Am J Hematol. 2024 Feb;99(2):327-328. PubMed PMID: 37073551
• Mejia Saldarriaga M, Pan D, Unkenholz C, Mouhieddine TH, Velez-Hernandez JE, Engles K, Fein JA, Monge J, Rosenbaum C, Pearse R, Jayabalan D, Gordillo C, Chan HT, Yamshon S, Thibaud S, Mapara M, Inghirami G, Lentzsch S, Reshef R, Rossi A, Parekh S, Jagannath S, Richard S, Niesvizky R, Bustoros M. Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma. Blood Adv. 2024 Aug 13;8(15):3859-3869. PubMed PMID: 38776397
• Kassner J, Abdellatif B, Yamshon S, Monge J, Kaner J. Current landscape of CD3 bispecific antibodies in hematologic malignancies. Trends Cancer. 2024 Aug;10(8):708-732. PubMed PMID: 38987076
• Monge J, Chadburn A, Gergis U. Synchronous multiple myeloma and Gaucher disease. Hematol Oncol Stem Cell Ther. 2020 Mar;13(1):42-45. PubMed PMID: 31622574
• Hernandez GA, Blumer V, Arcay L, Monge J, Viles-Gonzalez JF, Lindenfeld J, Goldberger JJ, Chaparro S. Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients: A Systematic Review and Meta-Analysis. JACC Heart Fail. 2018 Sep;6(9):734-742. PubMed PMID: 30098968
• Kortüm KM, Langer C, Monge J, Bruins L, Zhu YX, Shi CX, Jedlowski P, Egan JB, Ojha J, Bullinger L, Kull M, Ahmann G, Rasche L, Knop S, Fonseca R, Einsele H, Stewart AK, Braggio E. Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P). Ann Hematol. 2015 Jul;94(7):1205-11. PubMed PMID: 25743686
• Kortüm KM, Langer C, Monge J, Bruins L, Egan JB, Zhu YX, Shi CX, Jedlowski P, Schmidt J, Ojha J, Bullinger L, Liebisch P, Kull M, Champion MD, Van Wier S, Ahmann G, Rasche L, Knop S, Fonseca R, Einsele H, Stewart AK, Braggio E. Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease. Br J Haematol. 2015 Feb;168(4):507-10. PubMed PMID: 25302557
• Angelini P, Uribe C, Monge J, Tobis JM, Elayda MA, Willerson JT. Origin of the right coronary artery from the opposite sinus of Valsalva in adults: characterization by intravascular ultrasonography at baseline and after stent angioplasty. Catheter Cardiovasc Interv. 2015 Aug;86(2):199-208. PubMed PMID: 26178792
• Gordon GW, Monge J, Channon MB, Wu Q, Skulan JL, Anbar AD, Fonseca R. Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition. Leukemia. 2014 Oct;28(10):2112-5. PubMed PMID: 24919808
• Fonseca R, Monge J, Dimopoulos MA. Staging and prognostication of multiple myeloma. Expert Rev Hematol. 2014 Feb;7(1):21-31. PubMed PMID: 24483346
• Fonseca R, Monge J. Myeloma: classification and risk assessment. Semin Oncol. 2013 Oct;40(5):554-66. PubMed PMID: 24135400
• Angelini P, Monge J, Simpson L. Biventricular takotsubo cardiomyopathy: case report and general discussion. Tex Heart Inst J. 2013;40(3):312-5. PubMed PMID: 23914029
• Monge J, Braggio E, Ansell SM. Genetic factors and pathogenesis of Waldenström's macroglobulinemia. Curr Oncol Rep. 2013 Oct;15(5):450-6. PubMed PMID: 23901022
• Angelini P, Monge J. Newer concepts regarding adults with coronary artery aneurysms: are they all Kawasaki? Does it make a difference?. Circulation. 2012 Jun 26;125(25):3076-8. PubMed PMID: 22595320
• Angelini P, Uribe C, Monge J, Escobar JM, Hernandez-Vila E. Apical hypertrophic cardiomyopathy: preliminary attempt at palliation with use of subselective alcohol ablation. Tex Heart Inst J. 2012;39(5):750-5. PubMed PMID: 23109786
• Mohan M, Monge J, Shah N, Luan D, Forsberg M, Bhatlapenumarthi V, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, D'Souza A, Szabo A, Schinke C, Chakraborty R. Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood Cancer J. 2024 Mar 5;14(1):35. PubMed PMID: 38443345
• Mejia Saldarriaga M, Darwiche W, Jayabalan D, Monge J, Rosenbaum C, Pearse RN, Niesvizky R, Bustoros M. Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance. Front Oncol. 2022;12:1020011. PubMed PMID: 36387095
• Ghalehsari N, Zahid S, Main O, Usta S, Patresan J, Amin A, Ashraf F, Mazloom A, Huang A, Goldfinger M, Monge J. Exploring health disparities in diagnosing multiple myeloma. Expert Rev Hematol. 2024 Aug 8;:1-5. [Epub ahead of print] PubMed PMID: 39104264
• Gong Z, Umoru G, Monge J, Shah N, Mohyuddin GR, Radhakrishnan SV, Chakraborty R, Rasche L, Schinke C, D'Souza A, Mohan M. Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood Cancer J. 2024 Mar 5;14(1):36. PubMed PMID: 38443341
• Bradley T, Kwon D, Monge J, Sekeres M, Chandhok N, Thomassen A, Swords R, Padron E, Lancet J, Talati C, Watts J. Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia. EJHaem. 2022 Nov;3(4):1231-1240. PubMed PMID: 36467830
• Baljevic M, Gasparetto C, Schiller GJ, Tuchman SA, Callander NS, Lentzsch S, Monge J, Kotb R, Bahlis NJ, White D, Chen CI, Sutherland HJ, Madan S, LeBlanc R, Sebag M, Venner CP, Bensinger WI, Biran N, DeCastro A, Van Domelen DR, Zhang C, Shah JJ, Shacham S, Kauffman MG, Bentur OS, Lipe B. Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatment. EJHaem. 2022 Nov;3(4):1270-1276. PubMed PMID: 36467792
• Joggerst S, Monge J, Uribe C, Sherron S, Angelini P. Sudden cardiac arrest at the finish line: in coronary ectopia, the cause of ischemia is from intramural course, not ostial location. Tex Heart Inst J. 2014 Apr;41(2):212-6. PubMed PMID: 24808787

Professional Memberships

• American Society of Hematology, Member
• International Myeloma Society, Member
• International Myeloma Working Group, Member

Practice Locations

• University of Colorado Hospital

• University of Colorado Cancer Center

Specialty Information

• Hematology and Oncology, Board Certification

• Cancers - Myeloma
• Cancers
• Cancers - Amyloid